Evidence map›Paper›PMID 35259280›Full record

ArticleStem cells translational medicine2022

T-cadherin Expressing Cells in the Stromal Vascular Fraction of Human Adipose Tissue: Role in Osteogenesis and Angiogenesis.

Julien Guerrero, Boris Dasen, Agne Frismantiene, Sebastien Pigeot, Tarek Ismail, Dirk J Schaefer, Maria Philippova, Therese J Resink, Ivan Martin, Arnaud Scherberich

Open access · goldAbstract read
In one paragraph

Article in Stem cells translational medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Julien GuerreroDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Boris DasenDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Agne FrismantieneDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Sebastien PigeotDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Tarek IsmailDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Dirk J SchaeferDepartment of Plastic, Reconstructive, Aesthetic and Hand Surgery, University Hospital Basel, Basel, Switzerland.
Maria PhilippovaDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Therese J ResinkDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Ivan MartinDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.
Arnaud ScherberichDepartment of Biomedicine, University Hospital Basel, University of Basel, Basel, Switzerland.ORCID 0000-0003-3468-6955
University of Basel · CHUniversity Hospital of Basel · CH

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cells of the stromal vascular fraction (SVF) of human adipose tissue have the capacity to generate osteogenic grafts with intrinsic vasculogenic properties. However, cultured adipose-derived stromal cells (ASCs), even after minimal monolayer expansion, lose osteogenic capacity in vivo. Communication between endothelial and stromal/mesenchymal cell lineages has been suggested to improve bone formation and vascularization by engineered tissues. Here, we investigated the specific role of a subpopulation of SVF cells positive for T-cadherin (T-cad), a putative endothelial marker. We found that maintenance during monolayer expansion of a T-cad-positive cell population, composed of endothelial lineage cells (ECs), is mandatory to preserve the osteogenic capacity of SVF cells in vivo and strongly supports their vasculogenic properties. Depletion of T-cad-positive cells from the SVF totally impaired bone formation in vivo and strongly reduced vascularization by SVF cells in association with decreased VEGF and Adiponectin expression. The osteogenic potential of T-cad-depleted SVF cells was fully rescued by co-culture with ECs from a human umbilical vein (HUVECs), constitutively expressing T-cad. Ectopic expression of T-cad in ASCs stimulated mineralization in vitro but failed to rescue osteogenic potential in vivo, indicating that the endothelial nature of the T-cad-positive cells is the key factor for induction of osteogenesis in engineered grafts based on SVF cells. This study demonstrates that crosstalk between stromal and T-cad expressing endothelial cells within adipose tissue critically regulates osteogenesis, with VEGF and adiponectin as associated molecular mediators.

Indexed as

Endothelial CellsOsteogenesisAdiponectinAdipose TissueCadherinsCell DifferentiationCells, CulturedHumansStromal CellsStromal Vascular FractionT-LymphocytesVascular Endothelial Growth Factor AAdiponectinCadherinsH-cadherinVascular Endothelial Growth Factor A3D microenvironmentadipose stem cellsangiogenesisblood vesselsboneosteogenesis

Identifiers

PMID35259280
PMCPMC8929526
OpenAlexW4206133482

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.